Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.
Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive.

But when a dividend yield

AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.
AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.
AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.
EQS-News: Newron announces approval for pivotal Phase III  ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
EQS-News: Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
EQS-News: Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
3 Monster Stocks in the Making
3 Monster Stocks in the Making

Think of some of the biggest and most successful stocks on the market. Now, go back 20 or 30 years. Some of them didn't even exist that long ago. Others were only a fraction of their current size.

Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times
Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times

J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to trade wars and tariffs. The raging bull market that started at the beginning of 2023 is in

Is It Time to Turn Bullish on AMD Stock?
Is It Time to Turn Bullish on AMD Stock?

Could Advanced Micro Devices (NASDAQ: AMD be on the road to recovery?

The chipmaker reported its earnings for the first quarter of 2025, and its revenue growth is accelerating, with all but one

2 Beaten-Down AI Stocks to Buy in May
2 Beaten-Down AI Stocks to Buy in May

Artificial intelligence (AI) is completely reshaping how businesses operate. It promises to speed up productivity, product development, innovation, and economic growth, which is why organizations

2 High-Yield Dividend Stocks to Buy in May and Hold Forever
2 High-Yield Dividend Stocks to Buy in May and Hold Forever

When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but the most critical factor to consider is a company's underlying operations.

3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever
3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever

There are a few things that Ford Motor Company (NYSE: F), Target (NYSE: TGT), and Pfizer (NYSE: PFE), have in common. They are all components of the prestigious S&P 500. The stocks all pay a

3 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run
3 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run

Over the past decade, more companies recognized the disruptive potential of artificial intelligence (AI) applications across multiple industries. AI services could be used to automate repetitive

EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves dividend increase – Inclusion of the preferred shares in the TecDAX
EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves dividend increase – Inclusion of the preferred shares in the TecDAX
EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves dividend increase – Inclusion of the preferred shares in the TecDAX
Nvidia and AMD Stocks Jump on Reports That Trump Will Ease AI Chip Export Restrictions
Nvidia and AMD Stocks Jump on Reports That Trump Will Ease AI Chip Export Restrictions

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA). To learn more, check out the short video, consider subscribing, and click the

Is AMD Becoming a Serious Threat to Nvidia Stock Investors?
Is AMD Becoming a Serious Threat to Nvidia Stock Investors?

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA). To learn more, check out the short video, consider subscribing, and click the

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has

2 Unstoppable Dividend Stocks to Buy and Hold Forever
2 Unstoppable Dividend Stocks to Buy and Hold Forever

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past few decades, and that the lion's share of market returns can be

2 Beaten-Down Stocks That Are Great Buys on the Dip
2 Beaten-Down Stocks That Are Great Buys on the Dip

Even when equities are volatile, investors can find great stocks to buy. And the rules for investing in the current environment aren't that different, at least for those focused on the long game

Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks
Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks

The average stock on the S&P 500 yields just 1.4%. If you invested $54,000 into stocks averaging that kind of a yield, you'd collect just $756 in annual dividend income. But if you invested that

3 High-Yielding Dividend Stocks That Haven't Been This Cheap in Years
3 High-Yielding Dividend Stocks That Haven't Been This Cheap in Years

Buying a quality dividend stock near a multiyear low can be a great move, especially if you're willing to be patient and hang on for the long term. As long as the dividend remains intact, the yield

EQS-News: RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed
EQS-News: RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed
EQS-News: RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed
Why Geron Stock Crept Higher Today
Why Geron Stock Crept Higher Today

Shares of commercial-stage biotech Geron (NASDAQ: GERN) couldn't quite surmount the hump of Hump Day. After the company released its latest set of quarterly figures, its stock price wobbled as

What's Going On With AMD Stock After Earnings?
What's Going On With AMD Stock After Earnings?

In this video, I will cover Advanced Micro Devices' (NASDAQ: AMD) recent earnings report and explain why the stock barely moved after a strong earnings beat. Watch the short video to learn more

Why Rigetti Computing Stock Soared in April
Why Rigetti Computing Stock Soared in April

Shares of Rigetti Computing (NASDAQ: RGTI) surged higher in April. The company's stock gained 12% over the course of the month. The strong performance came as the S&P 500 and the Nasdaq Composite

Is AT&T Stock a Buy Now?
Is AT&T Stock a Buy Now?

Venerable telecom titan AT&T (NYSE: T) is on a roll. Its shares soared to a 52-week high of $29.03 in April, the highest it's been since before the COVID-19 pandemic.This result is a dramatic

Lisa Su Just Gave Amazing News to AMD Stock Investors
Lisa Su Just Gave Amazing News to AMD Stock Investors

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

Can Summit Therapeutics Stock Double Your Money?
Can Summit Therapeutics Stock Double Your Money?

Summit Therapeutics (NASDAQ: SMMT) has more than just a potential blockbuster cancer drug in its portfolio. Ivonescimab could be one of the best drugs to ever hit the market. This has investors